Teva nabs FDA approval for Cozaar, Hyzaar; GSK Consumer Healthcare plots Indian investment;

@FiercePharma:Sanofi lays off 400 more U.S. sales reps. Article | | Follow @FiercePharma

> Teva Pharmaceutical Industries has won U.S. approval for its generic versions of Merck's blockbuster blood-pressure drugs Cozaar and Hyzaar. Release

> GlaxoSmithKline Consumer Healthcare will invest more than 2.7 billion rupees (about $60 million) in its Indian operations over the next three years, the Economic Times reported. Report

> Adding to evidence that the acne drug  Accutane (isotretinoin) may lead to bowel disease in some users, a study finds that patients on the medication were four times more likely to develop ulcerative colitis within a year. Report

> Roche's Genentech is just weeks away from starting to ramp up production at its $400 million campus in Hillsboro, Oregon. Report

> GlaxoSmithKline has launched new TV spots for Lovaza, a prescription omega-3 fish oil capsule indicated for the lowering of very high triglyceride levels. Report

> Eli Lilly says U.S. regulators are still reviewing its application for an additional use of the antidepressant Cymbalta for chronic pain. Report

> Paladin Labs says Health Canada has approved Seasonique, a birth-control pill manufactured by a Teva Pharmaceutical Industries unit. Report

> Valeant Pharmaceuticals sold $400 million of senior unsecured notes in a private placement, $50 million more than the originally planned $350 million issue. Report

Biotech News

 @FierceBiotech: Explosion of cancer drug trials spurs a new approach. Article  | Follow @FierceBiotech

 @JohnCFierce: Tengion is looking for $35M out of an IPO this week. The strategy: Aim real low and keep your fingers crossed. Article | Follow @JohnCFierce

> Achaogen raises $56 million for antibiotic work. Report

> Generex sues TheStreet, Feuerstein for $250 million. Item

> Michigan biotech plan brings in 250 jobs. Story

> Alimera files $87 million IPO. Article

Medical Device News

> Medtronic to appeal CoreValve jury verdict. Story

> Boston Scientific's feud with former sales rep heats up. Item

> Judge delays decision on Guidant-Justice settlement after plaintiffs cry foul. Report

> Edwards Lifesciences gets FDA warning letter for reporting delay. Article

And Finally... An analysis of dietary data from more than 400,000 men and women found only a weak association between high fruit and vegetable intake and reduced overall cancer risk. Report

Virtual Clinical Trials Summit

Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials

In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.